Homelessness among people over the age of 50 is on the rise, a phenomenon formal housing strategies often overlook — but researchers from the University of Toronto and McGill hope to prevent this oversight in the future.
Amgen touts new data for drug MariTide, moving rapidly into Phase 3 work
Amgen said that an interim look at a Phase 2 trial of its anti-obesity drug MariTide had left the company “very encouraged,” and it planned
May 3, 2024